Latest 8-K filings

IDEXX Laboratories announced robust second quarter results, exceeding expectations with significant revenue growth and increased earnings per share, leading to an upward revision of its full-year financial guidance.

Vivid Seats Inc. announced its second quarter 2026 financial results, reporting a net loss of $14.3 million and a decrease in Marketplace Gross Order Value (GOV) and orders compared to the prior year, though it raised its full-year GOV outlook.

Caterpillar Inc. announced record-breaking second-quarter 2026 results, with sales and revenues climbing 24% to $20.5 billion, driven by strong volume and price realization across all segments.

InfuSystem Holdings, Inc. announced its second quarter 2026 financial results, showcasing a 2.6% increase in net revenues to $36.9 million and a 7.6% rise in Adjusted EBITDA to $8.6 million, while reaffirming full-year guidance.

ADI Global Distribution Inc. has successfully separated from Resideo Technologies, Inc., commencing independent trading on the NYSE under the ticker ADIG, marking a significant milestone for the specialty distributor.

Apollo Global Management announced robust second quarter 2026 financial results, driven by record earnings in Asset Management and Retirement Services, and a significant increase in Assets Under Management.

PSQ Holdings announced a 108% year-over-year revenue increase for Q2 2026, alongside significant improvements in operating loss and cash flow, while also divesting a non-core brand.

Trex Company announced record second quarter 2026 revenue of $418 million, driven by broad-based volume growth, and is accelerating its Arkansas expansion to meet increased consumer demand.

Revvity, Inc. announced its second quarter 2026 financial results, reporting revenue of $730 million and adjusted EPS of $1.41, while also entering an agreement to divest its China Immunodiagnostics business for up to $200 million.

Resideo Technologies, Inc. announced the completion of its spin-off of ADI Global Distribution Inc., establishing Resideo as a pure-play building technologies company and repaying $900 million in debt.

American Strategic Investment Co. announced the release date for its second quarter 2026 financial results, scheduled for August 12, 2026, before market open.

Fusemachines Inc. has closed a $2.5 million investment from existing investor Meteora Capital via a convertible note and warrants, aiming to fund growth and AI platform development.

Henry Schein announced robust second-quarter 2026 financial results, exceeding prior expectations and leading to an upward revision of its full-year 2026 financial guidance.

Waters Corporation announced robust second quarter 2026 financial results, exceeding guidance with strong revenue growth and raising its full-year financial outlook.

Ingredion Incorporated announced its second quarter 2026 financial results, reporting a decrease in operating income and EPS, while reaffirming full-year guidance and progressing with the Tate & Lyle acquisition.

Lipocine Inc. announced its second quarter 2026 financial results and provided a corporate update, highlighting a missed primary endpoint in its LPCN 1154 Phase 3 trial for postpartum depression.

DuPont de Nemours, Inc. reported strong second quarter 2026 results, surpassing financial guidance and leading to an upward revision of its full-year 2026 financial outlook.

Quanta Services announced the pricing of a $2 billion senior notes offering across three tranches with varying maturities and interest rates.

Archer-Daniels-Midland Company reported robust second-quarter 2026 results, exceeding expectations and leading to a significant increase in its full-year adjusted earnings per share guidance.

Eve Holding, Inc. has issued a press release detailing its financial results for the second quarter of 2026.

Pyrophyte Acquisition Corp. reports on the extension of its business combination deadline and subsequent sponsor deposits into its trust account.

Qnity Electronics announced robust second quarter 2026 results, with net sales up 22% year-over-year, and raised its full-year financial guidance.

IDEAYA Biosciences announced positive Q2 2026 financial results, highlighted by a registrational trial success for darovasertib and a strengthened cash position extending runway to 2030.

Prologis, Inc. announced a recommended offer to acquire SEGRO plc for approximately £14.0 billion, aiming to enhance its global logistics real estate platform.

Gartner reported strong second quarter 2026 results, exceeding expectations for Adjusted EPS and Adjusted EBITDA, and increased full-year guidance.

Lisata Therapeutics announced a 72% workforce reduction, estimated $1.2 million in costs, and initiated legal action against Kuva Labs for breach of a merger agreement.

FB Bancorp, Inc. announced the retirement of Dr. Stephen W. Hales from its Board of Directors and appointed Mark Romig as Chair of the Nominating/Governance Committee.

Galera Therapeutics, Inc. has completed its merger with Obsidian Therapeutics, Inc., becoming a wholly owned subsidiary and ceasing its OTCQB listing.

Vivos Therapeutics, Inc. announces the departure of its CFO, Bradford Amman, and the appointment of Roman Franklin as interim CFO through a services agreement with The CFO Portal, LLC.

8x8, Inc. announced the results of its 2026 Annual Meeting of Stockholders, with overwhelming support for director elections, executive compensation, and an amendment to its equity incentive plan.